Ban of menthol cigarettes help smokers to quit, reaffirmed by new study - Video
|
Overview
A new study concludes that the 2020 European ban on menthol cigarettes made it more likely that menthol smokers would quit smoking, supporting previous Canadian research on the positive public health impact of banning menthol cigarettes.
The research team surveyed a national sample of adult smokers of menthol and non-menthol cigarettes in the Netherlands before and after the EU menthol ban. Of the menthol smokers surveyed before and after the ban, 26.1 per cent had quit smoking. This quit rate was higher than the control group of non-menthol smokers, of whom only 14.1 per cent had quit.
In fact, the increased quit rate of 12 per cent of menthol smokers after the European ban is greater than the increased quit rate of 7.3 per cent found in an ITC study of the menthol ban that was in effect across Canada in 2018.
For decades, tobacco companies have added menthol to cigarettes because it creates a cooling sensation that reduces the harshness of smoke. It makes it easier to start smoking, causing non-smoking youth to be more likely to progress to regular smoking and become addicted to nicotine.
For more than a decade, the World Health Organization and many other public health authorities have called on governments to ban menthol in cigarettes to reduce smoking.
On April 28, 2022, the U.S. Food and Drug Administration announced a proposed rule to ban menthol in cigarettes and cigars.
The Dutch study also found that one-third of menthol smokers reported continuing to smoke menthol cigarettes even after the ban. The tobacco industry markets a wide range of accessories to enable people to add menthol flavoring to tobacco products themselves.
Reference:
Geoffrey T. Fong et al, Impact of the European Union's menthol cigarette ban on smoking cessation outcomes: Longitudinal findings from the 2020–2021 ITC Netherlands Surveys, appears in the journal Tobacco Control.
Speakers
Isra Zaman
B.Sc Life Sciences, M.Sc Biotechnology, B.Ed
Isra Zaman is a Life Science graduate from Daulat Ram College, Delhi University, and a postgraduate in Biotechnology from Amity University. She has a flair for writing, and her roles at Medicaldialogues include that of a Sr. content writer and a medical correspondent. Her news pieces cover recent discoveries and updates from the health and medicine sector. She can be reached at editorial@medicaldialogues.in.
Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751
